Genetics of colorectal cancer. I. Non-polyposis and polyposis forms of hereditary colorectal cancer;Genetica van darmkanker. I. Non-polyposis- en polyposisvormen van erfelijke darmkanker

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 23, 1999, Pages 1201-1206

  Menko, F H ^a,b   Griffioen, G ^a,c   Wijnen, J Th ^a,c   Tops, C M J ^a,c   Fodde, R ^a,c   Vasen, H F A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Stichting Opsporing Erfelijke Tumoren   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; COLON POLYPOSIS; COLORECTAL CANCER; DNA SEQUENCE; FAMILIAL CANCER; FAMILIAL POLYPOSIS; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; ILEOANAL ANASTOMOSIS; MICROSATELLITE INSTABILITY; PENETRANCE; POLYPECTOMY; REVIEW; TUMOR SUPPRESSOR GENE;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENES, APC; GERM-LINE MUTATION; HAMARTOMA SYNDROME, MULTIPLE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NETHERLANDS; PEUTZ-JEGHERS SYNDROME;

EID: 0033526647     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Warthin AS. Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895-1913. Arch Intern Med 1913;12: 546-55.
2. Jeghers H, McKusick VA, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits. A syndrome of diagnostic significance. N Engl J Med 1949;241:993-1005, 1031-6.
3. Gardner EJ. A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am J Hum Genet 1951;3:167-76.
4. Wijnen J, Meera Khan P, Vasen H, Klift H van der, Mulder A, Leeuwen-Cornelisse I van, et al. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations. Am J Hum Genet 1997;61:329-35.
5. Luijt RB van der, Meera Khan P, Vasen HFA, Tops CMJ, Leeuwen-Cornelisse ISJ van, Wijnen JTh, et al. Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and Southern analysis. Hum Mutat 1997;9:7-16.
6. Menko FH, Wijnen JTh, Meera Khan P, Vasen HFA, Oosterwijk MH. Genetic counseling in hereditary nonpolyposis colorectal cancer. Oncology 1996;10:71-6.
7. Tops C. Presymptomatic DNA diagnosis of familial adenomatous polyposis [proefschrift]. Leiden: Rijksuniversiteit Leiden: 1996.
8. Sandler RS. Epidemiology and risk factors for colorectal cancer. Gastroenterol Clin N Am 1996;25:717-35.
9. Sandler RS, Galanko JC, Murray SC, Helm JF, Woosley JT. Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas. Gastroenterology 1998;114:441-7.
10. Burn J, Chapman PD, Bishop DT, Mathers J. Diet and cancer prevention: the Concerted Action Polyp Prevention (CAPP) studies. Proc Nutr Soc 1998;57:183-6.
11. Burke W, Petersen G, Lynch P, Botkin J, Daly M, Garber J, et al. Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. JAMA 1997;277:915-9.
12. Lynch HT, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 1997;93:84-99.
13. Vasen HFA, Wijnen JTh, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
14. Jass JR. Colorectal adenomas in surgical specimens from subjects with hereditary non-polyposis colorectal cancer. Histopathology 1995;27:263-7.
15. Aarnio M, Mustonen H, Mecklin J-P, Järvinen HJ. Prognosis of colorectal cancer varies in different high-risk conditions. Ann Med 1998;30:75-80.
16. Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J. Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 1996;77:1836-43.
17. Vasen HFA, Mecklin J-P, Meera Khan P, Lynch HT. The International Collaborative Group on Hereditary Non-polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
18. Menko FH, Verheijen RHM, Everhardt E, Louwé LA, Wijnen JTh, Band SC, et al. Endometrial cancer in four sisters: report of a kindred with presumed cancer family syndrome. Gynecol Oncol 1994;54:171-4.
19. Wijnen J, Klift H van der, Vasen H, Meera Khan P, Menko F, Tops C, et al. MSH2 genomic deletions are a frequent cause of HNPCC [letter]. Nat Genet 1998;20:326-8.
20. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer [letter]. Nat Genet 1997; 17:271-2.
21. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Meera Khan P, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting high-lights and Bethesda guidelines. J Natl Cancer Inst 1997;89:1758-62.
22. Thihodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996;56:4836-40.
23. Menko FH, Griffioen G, Wijnen JTh, Tops CMJ, Fodde R, Vasen HFA. Genetica van darmkanker. II. Erfelijke achtergrond van sporadische en familiaire darmkanker. Ned Tijdschr Geneeskd 1999; 143:1207-11.
24. Vasen HFA, Nagengasl FM, Meera Khan P. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome) [letter]. Lancet 1995;345:1183-4.
25. Weber T. Clinical surveillance recommendations adopted for HNPCC. Lancet 1996;348:465.
26. Järvinen HJ, Mecklin J-P, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
27. Jäger AC, Bisgaard ML, Myrhøj T, Bernstein I, Rehfeld JF, Nielsen FC. Reduced frequency of extracolonic cancers in hereditary non-polyposis colorectal cancer families with monoallelic hMLH1 expression. Am J Hum Genet 1997;61:129-38.
28. Bülow S. Familial adenomatous polyposis. Ann Med 1989;21:299-307.
29. Griffioen G, Bus PJ, Vasen HFA, Verspaget HW, Lamers CBHW. Extracolonic manifestations of familial adenomatous polyposis: desmoid tumours, and upper gastrointestinal adenomas and carcinomas. Scand J Gastroenterol Suppl 1998;225:85-91.
30. Soravia C, Berk T, Madlensky L, Mitri A, Cheng H, Gallinger S, et al. Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet 1998;62:1290-301.
31. Fodde R, Meera Khan P. Genotype-phenotype correlations at the adenomatous polyposis coli (APC) gene. Crit Rev Oncog 1995;6: 291-303.
32. Vasen HFA, Luijt RB van der, Slors JFM, Buskens E, Ruiter P de, Baeten CGM, et al. Molecular genetic tests as a guide to surgical management of familial adenomatous polyposis. Lancet 1996;348: 433-5.
33. Tomlinson IPM, Neale K, Talbot IC, Spigelman AD, Williams CB, Phillips RKS, et al. A modifying locus for familial adenomatous polyposis may be present on chromosome 1p35-p36. J Med Genet 1996;33:268-73.
34. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-47.
35. Hemminki A, Markie D, Tomlinson I, Avizicnyte E, Roth S, Loukola A, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998;391:184-7.
36. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-7.
37. 4 gene in juvenile polyposis. Science 1998;280:1086-8.